Fig. 1From: Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access programComputed tomography scans from a patient with metastatic Merkel cell carcinoma treated with avelumab. Stable disease at a baseline and b 2 months, and complete response at c 4 months and d 1 year after starting avelumab treatment. Images were provided by Dr. GrignaniBack to article page